• For patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer who have received at least two prior treatment regimens including one platinum-based chemotherapy
  • This study is designed to investigate the efficacy, safety, tolerability of a new drug, MEDI4736,
  • Participant qualification is determined by the presence of a specific genetic mutation of the tumor

Contact Candace LeBlanc 508-556-5431 or Marcy Kirkpatrick 508-556-5429 for more information.